Immune clues in hepatitis b: study aims to unlock better treatment
NCT ID NCT01796457
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how the immune system responds to chronic hepatitis B infection. Researchers will analyze blood samples from 40 adults already enrolled in larger treatment trials. The goal is to understand why some people respond better to therapy and how the disease progresses over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict how chronic hepatitis B will progress and which treatments work best for individual patients.
- What could go wrong
- This is an observational study that does not test a new treatment. It only looks at immune markers, so it may not lead to direct patient benefits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Beth Israel Deaconess Medical Center
Boston, Massachusetts, 02115, United States
-
California Pacific Medical Center
San Francisco, California, 94115, United States
-
Harborview Medical Center
Seattle, Washington, 98104, United States
-
Toronto Western Hospital Liver Centre
Toronto, Ontario, Canada
-
University of California San Francisco Medical Center
San Francisco, California, 94143, United States
-
University of Minnesota
Plymouth, Minnesota, 55446, United States
-
Virginia Commonwealth University Medical Center
Richmond, Virginia, 23298, United States
-
Virginia Mason Medical Center
Seattle, Washington, 98101, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple roadside test catch liver disease before it turns deadly?
- Hospital care model aims to treat opioid addiction and serious infections together
- Simple blood test aims to spot multiple cancers early
- Heart safety check for hepatitis b drug candidate
- Two-Drug combo aims to cure chronic hepatitis b
- Hepatitis b breakthrough? study checks if bepirovirsen response lasts